Singapore’s Plan on Meat Why the FDA Lifted the Pork Import Ban

Singapore, a small and densely populated city-state, has a high demand for meat, but a limited capacity to produce it locally. The country imports about 90% of its food, including meat, from various sources, such as Brazil, Australia, and the US¹. However, this dependence on imports poses several challenges and risks, such as the high cost, the environmental impact, and the food security.

To address these challenges and risks, Singapore has been pursuing a plan to produce lab-grown meat, also known as cultured meat or cell-based meat, which is made from animal cells grown in a bioreactor, without the need to raise or slaughter animals. Singapore aims to become a global leader and hub for the research, development, and production of lab-grown meat, and to meet 30% of its meat consumption from alternative sources by 2030.

The Ban of the FDA on Pork

The US Food and Drug Administration (FDA), the agency responsible for regulating food safety and quality, had imposed a ban on pork imports from Singapore in May 2023, due to the outbreak of African swine fever (ASF) in the country. ASF is a highly contagious and fatal disease that affects pigs, but not humans. The disease can spread through direct contact, contaminated feed, or pork products, and can cause severe economic losses and food shortages.

The ban of the FDA on pork imports from Singapore was based on the precautionary principle, which aims to prevent the introduction and spread of ASF in the US, which is the world’s largest pork producer and exporter. The ban also followed the guidelines and recommendations of the World Organization for Animal Health (OIE), which classifies countries according to their ASF status and risk .

The Lifting of the FDA Ban on Pork

The FDA lifted the ban on pork imports from Singapore in February 2024, after Singapore reported that it had successfully eradicated ASF from its territory, and that it had implemented strict biosecurity measures and surveillance systems to prevent the recurrence of the disease. The FDA also verified and confirmed the claims and the evidence provided by Singapore, and conducted an on-site inspection and audit of its pork production facilities and processes.

The lifting of the FDA ban on pork imports from Singapore was welcomed and applauded by both countries, as it signaled the restoration and enhancement of their trade and diplomatic relations, as well as their mutual trust and cooperation on food safety and security issues. The lifting of the ban also opened up new opportunities and markets for Singapore’s lab-grown meat industry, which had received the world’s first regulatory approval from the FDA in 2022, and which had been expanding and exporting its products to other countries, such as Japan, Israel, and Canada.